This study demonstrates that protein C inhibitor requires heparin to inactivate activated protein C in a plasma environment.
Answers are grounded in this paper and cite their sources.
Heparin may be required for PCI to inactivate APC in plasma; leaves open relevance to in vivo thrombosis or clinical anticoagulation.
Monoclonal antibodies specific for protein C inhibitor (PCI) partially blocked the inactivation of activated protein C (APC) in plasma, whereas in a purified system, the PCI activity could be completely blocked. The inactivation of APC in normal and in PCI-depleted plasma was similar in the absence of heparin. The addition of heparin did not change the rate of inactivation of APC in PCI-depleted plasma, whereas in normal plasma a rapid phase of inhibition of APC was followed by a slower phase of inhibition. The slower phase was identical to the rate of inhibition of APC in the absence of heparin. After incubation of normal plasma with a monoclonal antibody specific for PCI that blocked its activity, there was no difference in heparin-dependent or heparin-independent inhibition of APC. These results indicate that in the absence of heparin PCI is unable to inactivate APC in a plasma environment.
No takes yet. Share an insight, caveat, or question.
Meijers et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: